Fundraising FoxAdheron Therapeutics
Berkeley, US · Delaware corporation
Find your way into Adheron Therapeutics
Sign up to see every warm intro you have to Adheron Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Adheron Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
BB
Bob BalteraExecutive Chairman.
CT
Chris ThomajanChief Financial Officer.
HK
Hari KumarChief Executive Officer.
Board
DO
Doug OnsiBoard director
RD
Rajeev DadooBoard director
IP
Isai PeimerBoard director
RL
Ron LauferBoard director
DC
David CastaldiBoard director
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 1 round · 2015
▶$1.5MraisedJul 2015 · 5 investors · PharmaceuticalsRule 506(b)
▶$1.5MraisedJul 2015 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Bob BalteraDirector, Executive Officer
- Doug OnsiDirector
- Rajeev DadooDirector
- Chris ThomajanExecutive Officer
- Isai PeimerDirector
- Ron LauferDirector
- Hari KumarExecutive Officer, Director
- David CastaldiDirector
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- First sale
- Jul 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Adheron Therapeutics raised?
- Adheron Therapeutics has disclosed $1.5M raised across 1 round.
- Where is Adheron Therapeutics headquartered?
- Adheron Therapeutics is headquartered in Berkeley, US.